Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/20/2003WO2002103026A3 Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments
11/20/2003WO2002101045A3 Vanilloid receptor-related nucleic acids and polypeptides
11/20/2003WO2002096944A3 New heterotetrameric potassium channels and uses thereof
11/20/2003WO2002095011A3 Inactivation of genes of the mep pathway
11/20/2003WO2002090544A3 Protein-protein interactions in adipocyte cells (3)
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003WO2002088181A3 Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances
11/20/2003WO2002086051A3 Nucleic acid analysis by mass differentiable oligomers
11/20/2003WO2002085287A3 Minimal adenoviral vectors for immunization
11/20/2003WO2002083736A3 G-protein coupled receptor molecules and uses thereof
11/20/2003WO2002081678A8 Method of separating alleles
11/20/2003WO2002081666A3 Regulation of human phosphatase-like protein
11/20/2003WO2002079249A3 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
11/20/2003WO2002077293A3 Detection of fungal pathogens using the polymerase chain reaction
11/20/2003WO2002077246A3 Site-targeted transformation using amplification vectors
11/20/2003WO2002077235A3 Intracellular signaling molecules
11/20/2003WO2002077234A3 Compositions and methods relating to colon specific genes and proteins
11/20/2003WO2002072825A3 Human mrp5-like protein
11/20/2003WO2002070703A8 Cell visual characteristic-modifying sequences
11/20/2003WO2002070698A3 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity
11/20/2003WO2002070658A3 Compositions and methods for increasing amino acid absorption in mammals
11/20/2003WO2002066675A3 Methods for detecting mutations
11/20/2003WO2002066501A3 PROTEIN-PROTEIN INTERACTIONS IN $i(HELICOBACTER PYLORI)
11/20/2003WO2002062395A3 A method and system for introducing a gene into a human stem cell
11/20/2003WO2002061121A3 Methods of analysis of nucleic acids
11/20/2003WO2002061110A8 Nucleic acid derivatives
11/20/2003WO2002061072A3 Transgenic plants containing altered levels of steroid compounds
11/20/2003WO2002060935A3 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences
11/20/2003WO2002059335A3 Cytoplasmic gene inhibition or gene expression in transfected plants by a tobraviral vector
11/20/2003WO2002059317A3 Cub domain protein zcub3 and materials and methods for making it
11/20/2003WO2002058459A3 Transgenic trees having increased resistance to imidazolinone herbicides
11/20/2003WO2002057416A8 Improved biochip
11/20/2003WO2002057408A8 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same
11/20/2003WO2002055547A3 Sfrp and peptide motifs that interact with sfrp and methods of their use
11/20/2003WO2002052015A3 Self-replicating rna molecule from hepatitis c virus
11/20/2003WO2002046767A3 Diagnosis and treatment of alzheimer's disease
11/20/2003WO2002044417A9 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
11/20/2003WO2002040690A9 Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways
11/20/2003WO2002038744A3 Proteases
11/20/2003WO2002034953A9 Detection and quantification of human herpes viruses
11/20/2003WO2002034915A3 Preferred segments of neural thread protein and methods of using the same
11/20/2003WO2002016580A3 Flow-through system for lysate clarification and nucleic acid binding in a single step
11/20/2003WO2002014525A3 Expression vector using for animal cell
11/20/2003WO2002008469A9 Methods, systems, and articles of manufacture for evaluating biological data
11/20/2003WO2002002055A3 Antifungal compounds and methods of use
11/20/2003WO2001081541A3 Pcr-hybridization assays specific for integrated retroviruses
11/20/2003WO2001061006A9 Two pore potassium channels, nucleotide sequences encoding them, and methods of using same
11/20/2003WO2001049098A3 Alzheimer's disease secretase, app substrates therefor, and uses therefor
11/20/2003WO2001049097A3 Alzheimer's disease secretase, app substrates therefor, and uses therefor
11/20/2003US20030217393 Development of a stress-responsive promoter from maize
11/20/2003US20030217392 Trangenic plants coding protein kinase stress-related protein (PKSRP) for propagating offspring which are drought, cold and/or salt tolerant; agriculture; foods
11/20/2003US20030217390 Plant brassinolide responsive genes and use thereof
11/20/2003US20030217389 Comprises rapid alkalinization factor (RALF) polypeptide for use as plant growth regulator; agriculture
11/20/2003US20030217388 Methods of controlling reproduction in plants
11/20/2003US20030217387 Enhanced floral sink strength and increased stability of seed in plants
11/20/2003US20030217386 Transgenic fodder plants with an increased leaf starch content
11/20/2003US20030217385 Comprises insect-toxic peptide/fusion proteins for use in generating disease resistant plants; biological pest control; disease resistant plants
11/20/2003US20030217383 Propagation of disease/herbicide/stress resistant plants; biological pest control
11/20/2003US20030217382 Plant-derived molecules and genetic sequences encoding same and uses therefor
11/20/2003US20030217381 Resistance to acetohydroxycid synthase-inhibiting herbicides
11/20/2003US20030217380 Culture mixture for preservation of sperm and oocytes for in vitro fertilization; cryogenics
11/20/2003US20030217379 Defective tyrosine phosphatase animal model for diagnosing and treating diabetes and eating disorders
11/20/2003US20030217378 Preparing transgenic animal via nuclear transfer; animal models
11/20/2003US20030217377 Oligonucleotide-directed repair or alteration of genetic information
11/20/2003US20030217376 Comprise nucleotide sequences coding receptor polypeptide for use in screening pesticides; enzyme inhibitors; biological pest control
11/20/2003US20030217374 Genetically engineered rodent for use in generating immunoglobulins; genetic vaccines; antitumor agents; gene therapy
11/20/2003US20030217373 Transgenic animals bearing human Ig-lambda light chain genes
11/20/2003US20030217371 Therapeutic methods employing PAI-1 inhibitors and transgenic non-human animal for screening candidate PAI-1 inhibitors
11/20/2003US20030217370 Transgenic animal expressing alpha-synuclein and uses thereof
11/20/2003US20030216784 Cellular electromanipulation waveforms
11/20/2003US20030216563 Kinase Wee1 fusion protein compositions, nucleotide sequences, expression systems, and methods of use
11/20/2003US20030216559 Medical diagnosis using polypeptide; amplification, determination, calibration; monitoring immunotherapy
11/20/2003US20030216558 Novel compositions and methods for cancer
11/20/2003US20030216549 Comprises modified chemokine for use as antiinflammatory, viricidal or antiallergenic agent
11/20/2003US20030216546 Genetically engineered fusion proteins for use in diagnosis and treatment of cancer, viral infections, autoimmune and alloimmune diseases
11/20/2003US20030216545 Comprises nucleotide sequences coding g-protein coupled receptors for diagnosing and treating cancer
11/20/2003US20030216347 Genetic material composed of a polynucleotide complexed with an amphipathic compound, a polymer or a nonviral vector is delivered to the parenchymal cell altering its endogenous properties
11/20/2003US20030216346 Gene carrier
11/20/2003US20030216345 Apoptosis inducer and anticancer agent, especially an antisense oligonucleotide
11/20/2003US20030216344 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
11/20/2003US20030216343 Expression vectors for stimulating an immune response and methods of using the same
11/20/2003US20030216342 Expression vectors for stimulating an immune response and methods of using the same
11/20/2003US20030216340 Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
11/20/2003US20030216337 Composition and imaging methods for pharmacokinetic and pharmacodynamic evaluation of therapeutic delivery system
11/20/2003US20030216336 Suppression of nuclear factor-kappaB dependent processes using oligonucleotides
11/20/2003US20030216335 Treating endometriosis by contacting the subject with a nucleic acid that modulates the expression of VEGF, VEGFR1, and/or VEGFR2
11/20/2003US20030216333 Antisense modulation of glycogen synthase kinase3 alpha expression
11/20/2003US20030216332 Nucleic acid sequences that are shorter than wild-type dystrophin cDNA and that express mini-dystrophin peptides that function in a similar manner as wild-type dystrophin proteins; used to treat muscular distrophy
11/20/2003US20030216317 Protein having cell-recognizing activity and/or cytocidal activity
11/20/2003US20030216315 Modulation of immune response by non-peptide binding stress response polypeptides
11/20/2003US20030216304 Novel proteins and nucleic acids encoding same
11/20/2003US20030216296 Amino acid sequences that mediate effective delivery of nucleic acids into cells and tissues, optionally using liposomes
11/20/2003US20030216290 Methods and compositions of treating and/or preventing diabetic retinopathy with pericyte apoptosis inhibitors
11/20/2003US20030216288 Methods and compositions for treating aids and HIV-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules
11/20/2003US20030215956 Multi-well microfiltration apparatus
11/20/2003US20030215949 Dehydroascorbate reductase ("DHAR") genes and their uses
11/20/2003US20030215948 Comprises adenoviral particle with reduced binding responses to heparin sulfate proteoglycans (HSP) for use as tools in gene therapy and genetic engineering
11/20/2003US20030215947 Methods for enhancing targeted gene alteration using oligonucleotides
11/20/2003US20030215944 Comprise nucleotide sequences which target and suppress express for nucleic acids coding receptor protein for treating cancer and psoriasis; gene expression inhibition
11/20/2003US20030215943 Antisense modulation of apolipoprotein B expression
1 ... 2371 2372 2373 2374 2375 2376 2377 2378 2379 2380 2381 2382 2383 2384 2385 2386 2387 2388 2389 2390 2391 ... 4023